Delivery Order SPE2DX22D0010-SPE2D825FFH09
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$24K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,262.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 100 units of Concerta ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $15,770.41, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of Concerta ER 36 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,298.19 firm fixed-price delivery order is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $22,995.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36mg Concerta ER Tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,578.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Concerta ER 36 mg tablets, a medication commonly used to treat attention deficit hyperactivity disorder (ADHD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,877.92 firm fixed-price delivery order is for the supply of 4,566,210,161 tablets of Concerta ER 18 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,144.76 firm fixed-price delivery order is for the supply of Concerta ER Tabs 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the...
This federal contract award, valued at $14,210.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a completion date of February 25, 2025. The contract was not designated with a set-aside requirement,...
This federal contract award, valued at $1,957.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,567,829,305 units of the prescription medication Concerta ER 36 mg tablet. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $13,563.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) for Troop Support Medical, valued at $999,999,999 and running through November 2026. The awarded contract covers the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat...